期刊文献+

葫芦素B脂肪乳注射液处方及制备工艺的研究 被引量:4

Formulation and preparation of cucurbitacin B lipid emulsion
下载PDF
导出
摘要 目的确定葫芦素B脂肪乳注射液的最优处方和最佳制备工艺。方法利用高压均质技术制备葫芦素B脂肪乳注射液,分别对药物和磷脂的加入方式、均质压力和次数、pH值和灭菌方式等制备工艺进行了考察,对油相组成、磷脂、F68和油酸钠的用量及抗氧剂的选择进行了优化。结果确定了最终的处方和制备工艺:将葫芦素B与2.0%磷脂溶解于无水乙醇中,70℃氮气流下挥干无水乙醇后加入2.5%长链三酰甘油、7.5%中链三酰甘油及0.05%dl-α-生育酚,70℃继续搅拌使其溶解,2.5%注射用甘油、0.2%F68和0.3%油酸钠分散于适量注射用水中,70℃加热搅拌至溶解;油相加入水相至15 000 r.min-1高速搅拌5 min得初乳;将初乳pH值调至8.0,定容,40℃下,700 bar高压均质8次;灭菌条件为121℃热压蒸汽灭菌8 min。结论所制备葫芦素B脂肪乳注射液具有较好的物理化学稳定性。 Objective To optimize the formulation and preparation of cucurbitacin B lipid emulsion.Methods High pressure homogenization was used to prepare cucurbitacin B lipid emulsion.The factors influencing the stability of the lipid emulsion,such as the drug loading methods,homogenization conditions,pH,sterilization methods,oil phase composition,phospholipids,F68,sodium oleate and antioxidants were investigated.Results The final formulation and preparation were as follows: Cucurbitacin B and 2.0% lecithin were dissolved in dehydrated alcohol.After dissolving uniformly,the dehy-drated alcohol was evaporated with stream nitrogen at 70 ℃.Then,the mixture was dispersed in oil composed of LCT(2.5%),MCT(7.5%) and dl-α-tocopherol(0.05%).F68(0.2%) and glycerol(2.5%) were heated to 70 ℃ and agitated until uniformly dissolved.Finally,the oil phase was added slowly to the water phase with high speed shear mixing at 15 000 r.min-1 for 5 min to obtain coarse emulsion.The pH was adjusted to 8.0 and the volume made up by purified water.After that,the coarse emulsion was subjected to high-pressure homogenization at 700 bar for 8 cycles to get the final emulsion at 40 ℃.Then the emulsion was sterilized by autoclaving for 8 min at 121℃.Conclusion Cucurbitacin B lipid emulsion prepared in this study is stable.
出处 《中南药学》 CAS 2013年第6期428-432,共5页 Central South Pharmacy
关键词 葫芦素B 脂肪乳 处方 制备工艺 cucurbitacin B lipid emulsion formulation preparation
  • 相关文献

参考文献8

  • 1朱靖静,邹坤.葫芦素类四环三萜化合物的研究进展[J].三峡大学学报(自然科学版),2009,31(5):82-87. 被引量:14
  • 2Venkateswarlu V, Patlolla PR. Lipid microspheres as drug delivery systems [J]. Ind J Pharm Sci, 2001, 63 ( 6 ) : 450-458.
  • 3林巧平,周建平.药物载体脂肪乳的研究与应用[J].药学进展,2005,29(8):359-364. 被引量:13
  • 4Chansiri G, Lyons RT, Patel MV, et al. Effect of surface charge on the stability of oil/water emulsions during steam sterilization [J]. J Pharm Sci, 1999, 88 (4) : 454-458.
  • 5Groves M J, Wineberg M, Brain APR. The presence of liposomal material in phosphatide stabilized emulsions [J]. J Dispersion Sci Technol, 1985, 6: 237-243.
  • 6Bentley P, Davis S, Johnson O, et al. Purification of pluronic F68 for perfluorochemical emulsification [J]. J Phann Pharmacol, 1989, 41 (9) : 661-663.
  • 7Mizushima Y, Hamano T, Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion [J]. Ann Rheum Dis, 1982, 41 ( 3 ) : 263-267.
  • 8Abra RM, Hunt CA, Lau DT. Liposome disposition in vivo. VI. Delivery to the lung [J]. JPharm Sci, 1984, 73 ( 2 ) : 203-206.

二级参考文献63

共引文献25

同被引文献41

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部